Directors' Dealings

Bioquell plc

("Bioquell" or the "Company")

Directors' Dealings

As a result of the Tender Offer announced on 2 June 2016, and in the case of Nicholas Adams as a result of the issue of 26,817 shares to him pursuant to the exercise of share options, the following changes to the holdings of the following Directors and their connected persons will take place on 21 June 2016:

Notes

1. Christopher Mills is Chief Investment Officer and a member of Harwood Capital LLP which owns 27.5 per cent of the Company's issued share capital following the Tender Offer.

2. Nicholas Adams' holding of 513,698 Ordinary Shares includes those held by his wife, Letitia Adams.

3. Michael Roller's interest in the issued share capital of the Company following the Tender Offer rounds down to 0.0. per cent.

Save for the Directors listed above, none of the other Directors have any interests in the share capital of the Company.

Capitalised terms used in this announcement have the same meaning as given to them in the Circular.

If you have any questions please telephone the Shareholder Helpline on 0371 664 0321 (from inside the UK) and +44 371 664 0300 (from outside the UK). Lines are open from 9.00 a.m. to 5.30 p.m. (London time) Monday to Friday (except public holidays in England and Wales). Please note that Capita Asset Services cannot provide any financial, legal or tax advice and calls to these numbers may be monitored or recorded for security and training purposes. Calls to the Shareholder Helpline are charged at the standard geographic rate and will vary by provider. Calls to +44 371 664 0300 from outside the UK are charged at applicable international rates. Different charges may apply to calls made from mobile telephones.

Enquiries: